Role of non-canonical Wnt signaling in osteoblast maturation on microstructured titanium surfaces

Acta Biomaterialia

Volumn 7, Issue 6, 2011, Pages 2740-2750

  Olivares Navarrete, Rene ^a   Hyzy, Sharon L ^a   Hutton, Daphne L ^a   Dunn, Ginger R ^a   Appert, Christoph ^b   Boyan, Barbara D ^a   Schwartz, Zvi ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b INSTITUT STRAUMANN AG   (Switzerland)

Author keywords

Cell signaling; Gene expression; Osteoblast differentiation; Regulatory factors; Titanium surface roughness

Indexed keywords

CELL SIGNALING; MICROSTRUCTURE; OSTEOBLASTS; POLYMERASE CHAIN REACTION; SIGNALING; SURFACE ROUGHNESS; TISSUE CULTURE; TITANIUM;

CELL-BE; CELL/B.E; CELL/BE; GENES EXPRESSION; MG63 CELLS; OSTEOBLAST DIFFERENTIATION; REGULATORY FACTORS; TITANIA SURFACE ROUGHNESS; TITANIA SURFACES; WNT PATHWAY;

GENE EXPRESSION;

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; LIGAND; TITANIUM; WNT3A PROTEIN; WNT5A PROTEIN;

ADOLESCENT; ARTICLE; BONE REGENERATION; CELL DIFFERENTIATION; CELL MATURATION; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMPLANT; MALE; MOUSE; NONHUMAN; OSTEOBLAST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TISSUE CULTURE; UPREGULATION;

EID: 79955573487     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2011.02.030     Document Type: Article

References (71)

1. Schwartz Z, Kieswetter K, Dean DD, Boyan BD. Underlying mechanisms at the bone-surface interface during regeneration. J Periodontal Res 1997;32:166-71. (Pubitemid 127521669)
2. Bachle M, Kohal RJ. A systematic review of the influence of different titanium surfaces on proliferation, differentiation and protein synthesis of osteoblast-like MG63 cells. Clin Oral Implants Res 2004;15:683-92. (Pubitemid 40115756)
3. Meyer U, Buchter A, Wiesmann HP, Joos U, Jones DB. Basic reactions of osteoblasts on structured material surfaces. Eur Cell Mater 2005;9:39-49. (Pubitemid 41008177)
4. Zhao G, Raines AL, Wieland M, Schwartz Z, Boyan BD. Requirement for both micron- and submicron scale structure for synergistic responses of osteoblasts to substrate surface energy and topography. Biomaterials 2007;28:2821-9. (Pubitemid 46482664)
5. Zhao G, Zinger O, Schwartz Z, Wieland M, Landolt D, Boyan BD. Osteoblast-like cells are sensitive to submicron-scale surface structure. Clin Oral Implants Res 2006;17:258-64. (Pubitemid 43709392)
6. Olivares-Navarrete R, Hyzy S, Wieland M, Boyan BD, Schwartz Z. The roles of Wnt signaling modulators Dickkopf-1 (Dkk1) and Dickkopf-2 (Dkk2) and cell maturation state in osteogenesis on microstructured titanium surfaces. Biomaterials 2010;31:2015-24.
7. Easwaran V, Lee SH, Inge L, Guo L, Goldbeck C, Garrett E, et al. Beta-Catenin regulates vascular endothelial growth factor expression in colon cancer. Cancer Res 2003;63:3145-53. (Pubitemid 36735866)
8. Billiard J, Way DS, Seestaller-Wehr LM, Moran RA, Mangine A, Bodine PV. The orphan receptor tyrosine kinase Ror2 modulates canonical Wnt signaling in osteoblastic cells. Mol Endocrinol 2005;19:90-101. (Pubitemid 40065961)
9. Day TF, Guo X, Garrett-Beal L, Yang Y. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 2005;8:739-50. (Pubitemid 40585296)
10. Hu B, Nikolakopoulou AM, Cohen-Cory S. BDNF stabilizes synapses and maintains the structural complexity of optic axons in vivo. Development 2005;132:4285-98. (Pubitemid 41576690)
11. Hill TP, Spater D, Taketo MM, Birchmeier W, Hartmann C. Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell 2005;8:727-38. (Pubitemid 40585295)
12. Rodda SJ, McMahon AP. Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development 2006;133:3231-44. (Pubitemid 44404346)
13. Schwartz Z, Lohmann CH, Sisk M, Cochran DL, Sylvia VL, Simpson J, et al. Local factor production by MG63 osteoblast-like cells in response to surface roughness and 1,25-(OH)2D3 is mediated via protein kinase C- and protein kinase A-dependent pathways. Biomaterials 2001;22:731-41. (Pubitemid 32117617)
14. Fang M, Olivares-Navarrete R, Wieland M, Cochran DL, Boyan BD, Schwartz Z. The role of phospholipase D in osteoblast response to titanium surface microstructure. J Biomed Mater Res A 2010;93:897-909.
15. Takada I, Mihara M, Suzawa M, Ohtake F, Kobayashi S, Igarashi M, et al. A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-gamma transactivation. Nat Cell Biol 2007;9:1273-85. (Pubitemid 350042359)
16. Baksh D, Boland GM, Tuan RS. Cross-talk between Wnt signaling pathways in human mesenchymal stem cells leads to functional antagonism during osteogenic differentiation. J Cell Biochem 2007;101:1109-24. (Pubitemid 47253714)
17. Baksh D, Tuan RS. Canonical and non-canonical Wnts differentially affect the development potential of primary isolate of human bone marrow mesenchymal stem cells. J Cell Physiol 2007;212:817-26. (Pubitemid 47267551)
18. Rupp F, Scheideler L, Olshanska N, de Wild M, Wieland M, Geis-Gerstorfer J. Enhancing surface free energy and hydrophilicity through chemical modification of microstructured titanium implant surfaces. J Biomed Mater Res A 2006;76:323-34.
19. Zhao G, Schwartz Z, Wieland M, Rupp F, Geis-Gerstorfer J, Cochran DL, et al. High surface energy enhances cell response to titanium substrate microstructure. J Biomed Mater Res A 2005;74:49-58. (Pubitemid 41099250)
20. Raz P, Lohmann CH, Turner J, Wang L, Poythress N, Blanchard C, et al. 1alpha,25(OH)2D3 regulation of integrin expression is substrate dependent. J Biomed Mater Res A 2004;71:217-25. (Pubitemid 39362901)
21. Olivares-Navarrete R, Raz P, Zhao G, Chen J, Wieland M, Cochran DL, et al. Integrin alpha2beta1 plays a critical role in osteoblast response to micron-scale surface structure and surface energy of titanium substrates. Proc Natl Acad Sci U S A 2008;105:15767-72.
22. Fischer L, Boland G, Tuan RS. Wnt-3A enhances bone morphogenetic protein-2-mediated chondrogenesis of murine C3H10T1/2 mesenchymal cells. J Biol Chem 2002;277:30870-8.
23. Liu Y, Rubin B, Bodine PV, Billiard J. Wnt5a induces homodimerization and activation of Ror2 receptor tyrosine kinase. J Cell Biochem 2008;105:497-502.
24. Pierschbacher MD, Dedhar S, Ruoslahti E, Argraves S, Suzuki S. An adhesion variant of the MG-63 osteosarcoma cell line displays an osteoblast-like phenotype. Ciba Found Symp 1988;136:131-41.
25. Hattar S, Berdal A, Asselin A, Loty S, Greenspan DC, Sautier JM. Behaviour of moderately differentiated osteoblast-like cells cultured in contact with bioactive glasses. Eur Cell Mater 2002;4:61-9. (Pubitemid 38977706)
26. Yoshida T, Kikuchi M, Koyama Y, Takakuda K. Osteogenic activity of MG63 cells on bone-like hydroxyapatite/collagen nanocomposite sponges. J Mater Sci Mater Med 2010;21:1263-72.
27. Maniatopoulos C, Sodek J, Melcher AH. Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Res 1988;254:317-30.
28. Peter SJ, Liang CR, Kim DJ, Widmer MS, Mikos AG. Osteoblastic phenotype of rat marrow stromal cells cultured in the presence of dexamethasone, beta-glycerolphosphate, and L-ascorbic acid. J Cell Biochem 1998;71:55-62. (Pubitemid 28402544)
29. Stein GS, Lian JB, Owen TA. Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J 1990;4:3111-23.
30. Boskey AL, Gadaleta S, Gundberg C, Doty SB, Ducy P, Karsenty G. Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin. Bone 1998;23:187-96. (Pubitemid 28434662)
31. Lossdorfer S, Schwartz Z, Wang L, Lohmann CH, Turner JD, Wieland M, et al. Microrough implant surface topographies increase osteogenesis by reducing osteoclast formation and activity. J Biomed Mater Res A 2004;70:361-9. (Pubitemid 39145239)
32. Kieswetter K, Schwartz Z, Hummert TW, Cochran DL, Simpson J, Dean DD, et al. Surface roughness modulates the local production of growth factors and cytokines by osteoblast-like MG-63 cells. J Biomed Mater Res 1996;32:55-63. (Pubitemid 26272341)
33. Grigoryan T, Wend P, Klaus A, Birchmeier W. Deciphering the function of canonical Wnt signals in development and disease: conditional loss- and gain-of-function mutations of beta-catenin in mice. Genes Dev 2008;22:2308-41.
34. Tamura M, Nemoto E, Sato MM, Nakashima A, Shimauchi H. Role of the Wnt signaling pathway in bone and tooth. Front Biosci (Elite Ed) 2010;2:1405-13.
35. Yamaguchi TP, Bradley A, McMahon AP, Jones S. A Wnt5a pathway underlies outgrowth of multiple structures in the vertebrate embryo. Development 1999;126:1211-23. (Pubitemid 29182117)
36. Yoshikawa Y, Fujimori T, McMahon AP, Takada S. Evidence that absence of Wnt-3a signaling promotes neuralization instead of paraxial mesoderm development in the mouse. Dev Biol 1997;183:234-42. (Pubitemid 27148650)
37. Westendorf JJ, Kahler RA, Schroeder TM. Wnt signaling in osteoblasts and bone diseases. Gene 2004;341:19-39. (Pubitemid 39335880)
38. Daneman R, Agalliu D, Zhou L, Kuhnert F, Kuo CJ, Barres BA. Wnt/beta-catenin signaling is required for CNS, but not non-CNS, angiogenesis. Proc Natl Acad Sci U S A 2009;106:641-6.
39. Cheng SL, Shao JS, Cai J, Sierra OL, Towler DA. Msx2 exerts bone anabolism via canonical Wnt signaling. J Biol Chem 2008;283:20505-22.
40. Stevens JR, Miranda-Carboni GA, Singer MA, Brugger SM, Lyons KM, Lane TF. Wnt10b deficiency results in age dependent loss of bone mass and progressive reduction of mesenchymal progenitor cells. J Bone Miner Res 2010.
41. Reichsman F, Smith L, Cumberledge S. Glycosaminoglycans can modulate extracellular localization of the wingless protein and promote signal transduction. J Cell Biol 1996;135:819-27. (Pubitemid 26372935)
42. Ford CE, Ekstrom EJ, Andersson T. Wnt-5a signaling restores tamoxifen sensitivity in estrogen receptor-negative breast cancer cells. Proc Natl Acad Sci U S A 2009;106:3919-24.
43. Kummitha CM, Mayle KM, Christman 2nd MA, Deosarkar SP, Schwartz AL, McCall KD, et al. A sandwich ELISA for the detection of Wnt5a. J Immunol Methods 2010;352:38-44.
44. Rawadi G, Vayssiere B, Dunn F, Baron R, Roman-Roman S. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Miner Res 2003;18:1842-53. (Pubitemid 37322562)
45. Caverzasio J, Manen D. Essential role of Wnt3a-mediated activation of mitogen-activated protein kinase p38 for the stimulation of alkaline phosphatase activity and matrix mineralization in C3H10T1/2 mesenchymal cells. Endocrinology 2007;148:5323-30. (Pubitemid 350012642)
46. Zhang Y, Wang Y, Li X, Zhang J, Mao J, Li Z, et al. The LRP5 high-bone-mass G171V mutation disrupts LRP5 interaction with Mesd. Mol Cell Biol 2004;24:4677-84. (Pubitemid 38668035)
47. Bennett CN, Longo KA, Wright WS, Suva LJ, Lane TF, Hankenson KD, et al. Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc Natl Acad Sci U S A 2005;102:3324-9. (Pubitemid 40328044)
48. 2+/cGMP-signalling pathway in development. Biochem Soc Trans 2004;32:792-6.
49. Veeman MT, Axelrod JD, Moon RT. A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling. Dev Cell 2003;5:367-77.
50. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 2001;107:513-23. (Pubitemid 33152786)
51. Yadav VK, Ducy P. Lrp5 and bone formation: a serotonin-dependent pathway. Ann N Y Acad Sci 2010;1192:103-9.
52. Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, et al. High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 2002;346:1513-21. (Pubitemid 34755690)
53. Holmen SL, Giambernardi TA, Zylstra CR, Buckner-Berghuis BD, Resau JH, Hess JF, et al. Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6. J Bone Miner Res 2004;19:2033-40. (Pubitemid 41103418)
54. Dong YF, Soung do Y, Schwarz EM, O'Keefe RJ, Drissi H. Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor. J Cell Physiol 2006;208:77-86.
55. Nelson WJ, Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science 2004;303:1483-7. (Pubitemid 38314410)
56. Kim JB, Leucht P, Lam K, Luppen C, Ten Berge D, Nusse R, et al. Bone regeneration is regulated by wnt signaling. J Bone Miner Res 2007;22:1913-23. (Pubitemid 351229308)
57. Keeble TR, Halford MM, Seaman C, Kee N, Macheda M, Anderson RB, et al. The Wnt receptor Ryk is required for Wnt5a-mediated axon guidance on the contralateral side of the corpus callosum. J Neurosci 2006;26:5840-8. (Pubitemid 44315278)
58. Oishi I, Suzuki H, Onishi N, Takada R, Kani S, Ohkawara B, et al. The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway. Genes Cells 2003;8:645-54. (Pubitemid 36880848)
59. Nemeth MJ, Topol L, Anderson SM, Yang Y, Bodine DM. Wnt5a inhibits canonical Wnt signaling in hematopoietic stem cells and enhances repopulation. Proc Natl Acad Sci U S A 2007;104:15436-41. (Pubitemid 47502935)
60. Yamamoto S, Nishimura O, Misaki K, Nishita M, Minami Y, Yonemura S, et al. Cthrc1 selectively activates the planar cell polarity pathway of Wnt signaling by stabilizing the Wnt-receptor complex. Dev Cell 2008;15:23-36. (Pubitemid 351895602)
61. Nishita M, Yoo SK, Nomachi A, Kani S, Sougawa N, Ohta Y, et al. Filopodia formation mediated by receptor tyrosine kinase Ror2 is required for Wnt5a-induced cell migration. J Cell Biol 2006;175:555-62. (Pubitemid 44790609)
62. Nomachi A, Nishita M, Inaba D, Enomoto M, Hamasaki M, Minami Y. Receptor tyrosine kinase Ror2 mediates Wnt5a-induced polarized cell migration by activating c-Jun N-terminal kinase via actin-binding protein filamin A. J Biol Chem 2008;283:27973-81.
63. Boyan BD, Lossdorfer S, Wang L, Zhao G, Lohmann CH, Cochran DL, et al. Osteoblasts generate an osteogenic microenvironment when grown on surfaces with rough microtopographies. Eur Cell Mater 2003;6:22-7. (Pubitemid 38851419)
64. Cai Y, Mohseny AB, Karperien M, Hogendoorn PC, Zhou G, Cleton-Jansen AM. Inactive Wnt/beta-catenin pathway in conventional high-grade osteosarcoma. J Pathol 2010;220:24-33.
65. Dai J, Hall CL, Escara-Wilke J, Mizokami A, Keller JM, Keller ET. Prostate cancer induces bone metastasis through Wnt-induced bone morphogenetic protein-dependent and independent mechanisms. Cancer Res 2008;68:5785-94.
66. Buser D, Broggini N, Wieland M, Schenk RK, Denzer AJ, Cochran DL, et al. Enhanced bone apposition to a chemically modified SLA titanium surface. J Dent Res 2004;83:529-33. (Pubitemid 41766080)
67. Cochran DL, Buser D, ten Bruggenkate CM, Weingart D, Taylor TM, Bernard JP, et al. The use of reduced healing times on ITI implants with a sandblasted and acid-etched (SLA) surface: early results from clinical trials on ITI SLA implants. Clin Oral Implants Res 2002;13:144-53.
68. DeChiara TM, Kimble RB, Poueymirou WT, Rojas J, Masiakowski P, Valenzuela DM, et al. Ror2, encoding a receptor-like tyrosine kinase, is required for cartilage and growth plate development. Nat Genet 2000;24:271-4. (Pubitemid 30132196)
69. Takeuchi S, Takeda K, Oishi I, Nomi M, Ikeya M, Itoh K, et al. Mouse Ror2 receptor tyrosine kinase is required for the heart development and limb formation. Genes Cells 2000;5:71-8. (Pubitemid 30095682)
70. Wall I, Donos N, Carlqvist K, Jones F, Brett P. Modified titanium surfaces promote accelerated osteogenic differentiation of mesenchymal stromal cells in vitro. Bone 2009;45:17-26.
71. Schwartz Z, Olivares-Navarrete R, Wieland M, Cochran DL, Boyan BD. Mechanisms regulating increased production of osteoprotegerin by osteoblasts cultured on microstructured titanium surfaces. Biomaterials 2009;30:3390-6.